Cumberland Pharmaceuticals CPIX Other — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cumberland Pharmaceuticals’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's other — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's other — revenue?
- Cumberland Pharmaceuticals (CPIX) reported other — revenue of $1.03M in Q4 2025.
- How has Cumberland Pharmaceuticals's other — revenue changed year-over-year?
- Cumberland Pharmaceuticals's other — revenue increased by 210.1% year-over-year, from $332.56K to $1.03M.
- What is the long-term trend for Cumberland Pharmaceuticals's other — revenue?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's other — revenue has grown at a 44.7% compound annual growth rate (CAGR), from $939.78K to $4.13M.
- What does other — revenue mean?
- This metric represents the total gross revenue generated from business activities, products, or services that fall outside of the company's primary specialty pharmaceutical operating segments. It captures income streams from ancillary operations, licensing arrangements, or non-core product lines that contribute to the company's overall top-line performance. Monitoring this figure helps investors assess the diversification of revenue sources and the potential impact of non-core business initiatives on total corporate growth.